Bile Acids: A Communication Channel in the Gut-Brain Axis
- PMID: 33085065
- DOI: 10.1007/s12017-020-08625-z
Bile Acids: A Communication Channel in the Gut-Brain Axis
Abstract
Bile acids are signalling hormones involved in the regulation of several metabolic pathways. The ability of bile acids to bind and signal through their receptors is modulated by the gut microbiome, since the microbiome contributes to the regulation and synthesis of bile acids as well to their physiochemical properties. From the gut, bacteria have been shown to send signals to the central nervous system via their metabolites, thus affecting the behaviour and brain function of the host organism. In the last years it has become increasingly evident that bile acids affect brain function, during normal physiological and pathological conditions. Although bile acids may be synthesized locally in the brain, the majority of brain bile acids are taken up from the systemic circulation. Since the composition of the brain bile acid pool may be regulated by the action of intestinal bacteria, it is possible that bile acids function as a communication bridge between the gut microbiome and the brain. However, little is known about the molecular mechanisms and the physiological roles of bile acids in the central nervous system. The possibility that bile acids may be a direct link between the intestinal microbiome and the brain is also an understudied subject. Here we review the influence of gut bacteria on the bile acid pool composition and properties, as well as striking evidence showing the role of bile acids as neuroactive molecules.
Keywords: Bile acids; Gut microbiome; Gut-brain axis; Neurodegenerative disorders.
Similar articles
-
The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases.Biomed Pharmacother. 2025 Jul;188:118182. doi: 10.1016/j.biopha.2025.118182. Epub 2025 May 24. Biomed Pharmacother. 2025. PMID: 40413999 Review.
-
Role of Microbiota-Modified Bile Acids in the Regulation of Intracellular Organelles and Neurodegenerative Diseases.Genes (Basel). 2023 Mar 29;14(4):825. doi: 10.3390/genes14040825. Genes (Basel). 2023. PMID: 37107583 Free PMC article. Review.
-
Bile Acid Metabolism in Liver Pathobiology.Gene Expr. 2018 May 18;18(2):71-87. doi: 10.3727/105221618X15156018385515. Epub 2018 Jan 11. Gene Expr. 2018. PMID: 29325602 Free PMC article. Review.
-
The Role of the Gut Microbiota in Bile Acid Metabolism.Ann Hepatol. 2017 Nov;16(Suppl. 1: s3-105.):s15-s20. doi: 10.5604/01.3001.0010.5494. Ann Hepatol. 2017. PMID: 29080339 Review.
-
Consequences of bile salt biotransformations by intestinal bacteria.Gut Microbes. 2016;7(1):22-39. doi: 10.1080/19490976.2015.1127483. Gut Microbes. 2016. PMID: 26939849 Free PMC article. Review.
Cited by
-
Microbiota and Metabolite Profiling as Markers of Mood Disorders: A Cross-Sectional Study in Obese Patients.Nutrients. 2021 Dec 29;14(1):147. doi: 10.3390/nu14010147. Nutrients. 2021. PMID: 35011021 Free PMC article.
-
Postpartum Oxytocin Treatment via the Mother Reprograms Long-Term Behavioral Disorders Induced by Early Life Stress on the Plasma and Brain Metabolome in the Rat.Int J Mol Sci. 2024 Mar 5;25(5):3014. doi: 10.3390/ijms25053014. Int J Mol Sci. 2024. PMID: 38474260 Free PMC article.
-
A Novel Frontier in Gut-Brain Axis Research: The Transplantation of Fecal Microbiota in Neurodegenerative Disorders.Biomedicines. 2025 Apr 9;13(4):915. doi: 10.3390/biomedicines13040915. Biomedicines. 2025. PMID: 40299512 Free PMC article. Review.
-
Probiotic therapy modulates the brain-gut-liver microbiota axis in a mouse model of traumatic brain injury.Biochim Biophys Acta Mol Basis Dis. 2024 Dec;1870(8):167483. doi: 10.1016/j.bbadis.2024.167483. Epub 2024 Aug 28. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 39209236 Free PMC article.
-
Multi-Omics Characterization of Type 2 Diabetes Mellitus-Induced Cognitive Impairment in the db/db Mouse Model.Molecules. 2022 Mar 15;27(6):1904. doi: 10.3390/molecules27061904. Molecules. 2022. PMID: 35335269 Free PMC article.
References
-
- Adada, M., Canals, D., Hannun, Y. A., & Obeid, L. M. (2013). Sphingosine-1-phosphate receptor 2. FEBS Journal, 280(24), 6354–6366. - DOI
-
- Akahoshi, N., Ishizaki, Y., Yasuda, H., Murashima, Y. L., Shinba, T., Goto, K., et al. (2011). Frequent spontaneous seizures followed by spatial working memory/anxiety deficits in mice lacking Sphingosine 1-phosphate receptor 2. Epilepsy & Behavior, 22(4), 659–665. - DOI
-
- Amador, M. M., Masingue, M., Debs, R., Lamari, F., Perlbarg, V., Roze, E., et al. (2018). Treatment with chenodeoxycholic acid in Cerebrotendinous Xanthomatosis: Clinical, neurophysiological, and quantitative brain structural outcomes. Journal of Inherited Metabolic Disease, 41(5), 799–807. - PubMed - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources